Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mickael Hiligsmann

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
Archives of Osteoporosis|April 5, 2022
A Qualitative Study to Assess US Patient Preferences between new Transdermal System and Injectable Anabolic Therapies for Osteoporosis TreatmentCharlotte Beaudart, Stuart Silverman, Deborah T Gold, et al.
Developmental Medicine and Child Neurology|June 8, 2022
Financial cost and quality of life of patients with spinal muscular atrophy identified by symptoms or newborn screeningTamara Dangouloff, Mickael Hiligsmann, Nicolas Deconinck, et al.
International Journal of Technology Assessment in Health Care|December 21, 2021
Economic evaluation guidelines in low- and middle-income countries: a systematic reviewCaroline Daccache, Rana Rizk, Jalal Dahham, et al.
Rheumatology (Oxford, England)|December 29, 2016
Patients' preferences and economic considerations play an important role in treatment decisions: a discrete choice experiment among rheumatologistsMonika Hifinger, Mickael Hiligsmann, Sofia Ramiro, et al.
RMD Open|June 28, 2019
Development of one general and six country-specific algorithms to assess societal health utilities based on ASAS HIIvette Essers, Mickael Hiligsmann, Uta Kiltz, et al.
European Journal of Epidemiology|September 4, 2009
Loss of hip bone mineral density over time is associated with spine and hip fracture incidence in osteoporotic postmenopausal womenOlivier Bruyere, Alfredo Roces Varela, Silvio Adami, et al.
Seminars in Arthritis and Rheumatism|February 10, 2019
Cost-effectiveness of sequential treatment with abaloparatide vs. teriparatide for United States women at increased risk of fractureMickael Hiligsmann, Setareh A Williams, Lorraine A Fitzpatrick, et al.
Seminars in Arthritis and Rheumatism|March 13, 2020
Cost-effectiveness of sequential treatment with abaloparatide followed by alendronate vs. alendronate monotherapy in women at increased risk of fracture: A US payer perspectiveMickael Hiligsmann, Setareh A Williams, Lorraine A Fitzpatrick, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 27, 2024
Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Indian women: a Markov microsimulation model analysisLakshmi Nagendra, Manju Chandran, Jean-Yves Reginster, et al.
Journal of Medical Economics|February 27, 2020
A discrete choice experiment to assess patients' preferences for HIV treatment in the rural population in ColombiaAnne J M Goossens, Kei Long Cheung, Eric Sijstermans, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
Archives of Osteoporosis|April 5, 2022
A Qualitative Study to Assess US Patient Preferences between new Transdermal System and Injectable Anabolic Therapies for Osteoporosis TreatmentCharlotte Beaudart, Stuart Silverman, Deborah T Gold, et al.
Developmental Medicine and Child Neurology|June 8, 2022
Financial cost and quality of life of patients with spinal muscular atrophy identified by symptoms or newborn screeningTamara Dangouloff, Mickael Hiligsmann, Nicolas Deconinck, et al.
International Journal of Technology Assessment in Health Care|December 21, 2021
Economic evaluation guidelines in low- and middle-income countries: a systematic reviewCaroline Daccache, Rana Rizk, Jalal Dahham, et al.
Rheumatology (Oxford, England)|December 29, 2016
Patients' preferences and economic considerations play an important role in treatment decisions: a discrete choice experiment among rheumatologistsMonika Hifinger, Mickael Hiligsmann, Sofia Ramiro, et al.
RMD Open|June 28, 2019
Development of one general and six country-specific algorithms to assess societal health utilities based on ASAS HIIvette Essers, Mickael Hiligsmann, Uta Kiltz, et al.
European Journal of Epidemiology|September 4, 2009
Loss of hip bone mineral density over time is associated with spine and hip fracture incidence in osteoporotic postmenopausal womenOlivier Bruyere, Alfredo Roces Varela, Silvio Adami, et al.
Seminars in Arthritis and Rheumatism|February 10, 2019
Cost-effectiveness of sequential treatment with abaloparatide vs. teriparatide for United States women at increased risk of fractureMickael Hiligsmann, Setareh A Williams, Lorraine A Fitzpatrick, et al.
Seminars in Arthritis and Rheumatism|March 13, 2020
Cost-effectiveness of sequential treatment with abaloparatide followed by alendronate vs. alendronate monotherapy in women at increased risk of fracture: A US payer perspectiveMickael Hiligsmann, Setareh A Williams, Lorraine A Fitzpatrick, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 27, 2024
Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Indian women: a Markov microsimulation model analysisLakshmi Nagendra, Manju Chandran, Jean-Yves Reginster, et al.
Journal of Medical Economics|February 27, 2020
A discrete choice experiment to assess patients' preferences for HIV treatment in the rural population in ColombiaAnne J M Goossens, Kei Long Cheung, Eric Sijstermans, et al.
Pageof 9